RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Marrone Bio Innovations Debt 2024

Marrone Bio Innovations Debt

13.98 USD

Marrone Bio Innovations Dividend yield

Ticker

MBII

ISIN

US57165B1061

WKN

A1W30B

In 2024, Marrone Bio Innovations's total debt was 13.98 USD, a 0% change from the 0 USD total debt recorded in the previous year.

Marrone Bio Innovations Aktienanalyse

What does Marrone Bio Innovations do?

Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Marrone Bio Innovations's Debt Structure

Marrone Bio Innovations's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Marrone Bio Innovations's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Marrone Bio Innovations’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Marrone Bio Innovations’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Marrone Bio Innovations Stock

What is the debt of Marrone Bio Innovations this year?

Marrone Bio Innovations has a debt level of 13.98 USD this year.

What was the debt of Marrone Bio Innovations compared to the previous year?

The debt of Marrone Bio Innovations has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Marrone Bio Innovations?

High debt can pose a risk for investors of Marrone Bio Innovations, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Marrone Bio Innovations?

Low debt means that Marrone Bio Innovations has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Marrone Bio Innovations affect the company?

An increase in debt of Marrone Bio Innovations can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Marrone Bio Innovations affect the company?

A reduction in debt of Marrone Bio Innovations can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Marrone Bio Innovations?

Some factors that can influence the debt of Marrone Bio Innovations include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Marrone Bio Innovations so important for investors?

The debts of Marrone Bio Innovations are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Marrone Bio Innovations take to change the debt?

To change the debt, Marrone Bio Innovations can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Marrone Bio Innovations pay?

Over the past 12 months, Marrone Bio Innovations paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Marrone Bio Innovations is expected to pay a dividend of 0 USD.

What is the dividend yield of Marrone Bio Innovations?

The current dividend yield of Marrone Bio Innovations is .

When does Marrone Bio Innovations pay dividends?

Marrone Bio Innovations pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Marrone Bio Innovations?

Marrone Bio Innovations paid dividends every year for the past 0 years.

What is the dividend of Marrone Bio Innovations?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Marrone Bio Innovations located?

Marrone Bio Innovations is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Marrone Bio Innovations kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Marrone Bio Innovations from 4/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/28/2024.

When did Marrone Bio Innovations pay the last dividend?

The last dividend was paid out on 4/28/2024.

What was the dividend of Marrone Bio Innovations in the year 2023?

In the year 2023, Marrone Bio Innovations distributed 0 USD as dividends.

In which currency does Marrone Bio Innovations pay out the dividend?

The dividends of Marrone Bio Innovations are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Marrone Bio Innovations

Our stock analysis for Marrone Bio Innovations Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Marrone Bio Innovations Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.